FDA Approves First Drug for Prophylaxis of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients

American Society of Hematology. (2017).
FDA Approves First Drug for Prophylaxis of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients.
Retrieved from https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2017/first-drug-for-prophylaxis-of-cytomegalovirus-infection-disease-in-bone-marrow-transplant-patients.

American Society of Hematology.
"FDA Approves First Drug for Prophylaxis of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients." Hematology.org.
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2017/first-drug-for-prophylaxis-of-cytomegalovirus-infection-disease-in-bone-marrow-transplant-patients
(label-accessed April 23, 2024).

"American Society of Hematology."
FDA Approves First Drug for Prophylaxis of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients, 23 Apr. 2024 ,
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2017/first-drug-for-prophylaxis-of-cytomegalovirus-infection-disease-in-bone-marrow-transplant-patients.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero